Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Clin Cancer Res. 2021 Mar 22;27(11):3005–3016. doi: 10.1158/1078-0432.CCR-21-0315

Figure 1.

Figure 1.

Overview of schema (A) and schedule of study procedures (B) for canine OS patients enrolled in the Standard of Care (SOC) vs. SOC + sirolimus (SOC + S) clinical trials. CXR = 3-view thoracic (chest) radiographic assessment. PBMC = Peripheral Blood Mononuclear Cells. PE = Physical Exam. PD = Progressive Disease. PK = pharmacokinetic assessment of drug levels.